Transforming growth factor-β stimulates β amyloid uptake by microglia through Smad3-dependent mechanisms

Journal of Neuroscience Research

Volumn 90, Issue 10, 2012, Pages 1970-1980

  Tichauer, Juan E ^a   von Bernhardi, Rommy ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Alzheimer's disease; Cytokines; Glia; Neuroinflammation; SR A; Transforming growth factor

Indexed keywords

AMYLOID BETA PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SCAVENGER RECEPTOR; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; MICROGLIA; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION;

AMYLOID BETA-PEPTIDES; ANIMALS; BLOTTING, WESTERN; FREE RADICALS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; IMMUNOHISTOCHEMISTRY; MICROGLIA; NEUROGLIA; NITRIC OXIDE; PHAGOCYTOSIS; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SCAVENGER; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; TUBULIN;

EID: 84864857755     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23082     Document Type: Article

References (53)

1. Alarcón R, Fuenzalida C, Santibanez M, von Bernhardi R. 2005. Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid. J Biol Chem 280: 30406-30415.
2. Baig S, van Helmond Z, Love S. 2009. Tau hyperphosphorylation affects Smad 2/3 translocation. Neurosci 163: 561-570.
3. Block ML, Zecca L, Hong JS. 2007. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev 8: 57-69.
4. Campa VM, Iglesias JM, Carcedo MT, Rodriguez R, Riera J, Ramos S, Lazo PS. 2005. Polyinosinic acid induces TNF and NO production as well as NF-kappaB and AP-1 transcriptional activation in the monocytemacrophage cell line RAW 264.7. Inflamm Res 54: 328-337.
5. Chalmers KA, Love S. 2007. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons. J Neuropathol Exp Neurol 66: 158-167.
6. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. 2002. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70: 462-473.
7. Coraci IS, Husemann J, Berman JW, Hulette C, Dufour JH, Campanella GK, Luster AD, Silverstein SC, El-Khoury JB. 2002. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am J Pathol 160: 101-112.
8. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. 1996. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382: 716-719.
9. Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, Hoertnagl H, Raine CS, Schneider-Stock R, Nitsch R, Ullrich O. 2006. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49: 67-79.
10. Godoy B, Murgas P, Tichauer J, von Bernhardi R. 2012. Scavenger receptors class A ligands induce secretion of IL1β and exert a modulatory effect on inflammatory activation of astrocytes in culture. J Neuroimmunol (accepted).
11. Grathwohl SA, Kalin RE, Bolmont T, Prokop S, Winkelmann G, Kaeser SA, Odenthal J, Radde R, Eldh T, Gandy S, Aguzzi A, Staufenbiel M, Mathews PM, Wolburg H, Heppner FL, Jucker M. 2009. Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci 12: 1361-1363.
12. Gugan D, Baker TJ. 1986. Characterization of ameboid microglia isolated from devezo PIN6 mammalian brain. J Neurosci 8: 2163-2178.
13. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, et al. 1992. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325.
14. Hamaguchi T, Okino S, Sodeyama N, Itoh Y, Takahashi A, Otomo E, Matsushita M, Mizusawa H, Yamada M. 2005. Association of a polymorphism of the transforming growth factor-beta1 gene with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 76: 696-699.
15. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
16. Herrera-Molina R, von Bernhardi R. 2005. Transforming growth factor-beta 1 produced by hippocampal cells modulates microglial reactivity in culture. Neurobiol Dis 19: 229-236.
17. Huang F, Buttini M, Wyss-Coray T, McConlogue L, Kodama T, Pitas RE, Mucke L. 1999. Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors. Am J Pathol 155: 1741-1747.
18. Husemann J, Loike JD, Kodama T, Silverstein SC. 2001. Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar beta-amyloid. J Neuroimmunol 114: 142-150.
19. Husemann J, Loike JD, Anankov R, Febbraio M, Silverstein SC. 2002. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40: 195-205.
20. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. 2011. Physiology of microglia. Physiol Rev 91: 461-553.
21. Kleinert H, Schwarz PM, Forstermann U. 2003. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 384: 1343-1364.
22. Krieger M, Herz J. 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63: 601-637.
23. Lee HG, Ueda M, Zhu X, Perry G, Smith MA. 2006. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway? J Neurosci Res 84: 1856-1861.
24. Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM, Derynck R. 2007. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 26: 3957-3967.
25. Lesne S, Docagne F, Gabriel C, Liot G, Lahiri DK, Buee L, Plawinski L, Delacourte A, MacKenzie ET, Buisson A, Vivien D. 2003. Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. J Biol Chem 278: 18408-18418.
26. Marzolo MP, von Bernhardi R, Inestrosa NC. 1999. Mannose receptor is present in a functional state in rat microglial cells. J Neurosci Res 58: 387-395.
27. 2-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells. J Neurosci Res 60: 401-411.
28. Meda L, Baron P, Scarlato G. 2001. Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins. Neurobiol Aging 22: 885-893.
29. Motta M, Imbesi R, Di Rosa M, Stivala F, Malaguarnera L. 2007. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. Immunol Lett 114: 46-51.
30. Murgas P, Godoy B, von Bernhardi R. 2012. Aβ potentiates inflammatory activation of glial cells induced by Scavenger receptor ligands in culture. Neurotox Res DOI: 10.1007/s12640-011-9306-3.
31. Paresce DM, Ghosh RN, Maxfield FR. 1996. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17: 553-565.
32. Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M, Mathews PM, Jucker M. 2002. Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 298: 1379.
33. Pfeiffer S, Gorren AC, Schmidt K, Werner ER, Hansert B, Bohle DS, Mayer B. 1997. Metabolic fate of peroxynitrite in aqueous solution. Reaction with nitric oxide and pH-dependent decomposition to nitrite and oxygen in a 2:1 stoichiometry. J Biol Chem 272: 3465-3470.
34. Ramesh S, Qi XJ, Wildey GM, Robinson J, Molkentin J, Letterio J, Howe PH. 2008. TGF beta-mediated BIM expression and apoptosis are regulated through SMAD3-dependent expression of the MAPK phosphatase MKP2. EMBO Rep 9: 990-997.
35. Ramirez G, Rey S, von Bernhardi R. 2008. Proinflammatory stimuli are needed for induction of microglial cell-mediated AbetaPP_{244-C} and Abeta-neurotoxicity in hippocampal cultures. J Alzheimers Dis 15: 45-59.
36. Rigotti A, Acton SL, Krieger M. 1995. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 270: 16221-16224.
37. Rota E, Bellone G, Rocca P, Bergamasco B, Emanuelli G, Ferrero P. 2006. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. Neurol Sci 27: 33-39.
38. Sastre M, Klockgether T, Heneka MT. 2006. Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int J Dev Neurosci 24: 167-176.
39. Saud K, Herrera-Molina R, Von Bernhardi R. 2005. Pro- and anti-inflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells. Neurotox Res 8: 277-287.
40. Town T, Laouar Y, Pittenger C, Mori T, Szekely CA, Tan J, Duman RS, Flavell RA. 2008. Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med 14: 681-687.
41. Uribe-San Martín R, Herrera-Molina R, Olavarría L, Ramírez G, von Bernhardi R. 2009. Reduction of β-amyloid-induced neurotoxicity on hippocampal cell cultures by moderate acidosis is mediated by TGFβ. Neurosci 158: 1338-1347.
42. Van Berkel TJ, Van Velzen A, Kruijt JK, Suzuki H, Kodama T. 1998. Uptake and catabolism of modified LDL in scavenger-receptor class A type I/II knock-out mice. Biochem J 331: 29-35.
43. von Bernhardi R. 2007. Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotox Res 12: 215-232.
44. von Bernhardi R, Eugenín J. 2004. Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors. Brain Res 1025: 186-193.
45. von Bernhardi R, Ramirez G, Toro R, Eugenín J. 2007. Pro-inflammatory conditions promote neuronal damage mediated by amyloid precursor protein and decrease its phagocytosis and degradation by microglial cells in culture. Neurobiol Dis 26: 153-164.
46. Wrighton KH, Lin X, Feng XH. 2009. Phospho-control of TGF-beta superfamily signaling. Cell Res 19: 8-20.
47. Wyss-Coray T, Masliah E, Mallory M, McConlogue L, Johnson-Wood K, Lin C, Mucke L. 1997. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Nature 389: 603-606.
48. Wyss-Coray T, Lin C, Yan F, Yu GQ, Rohde M, McConlogue L, Masliah E, Mucke L. 2001. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med 7: 612-618.
49. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J. 2003. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9: 453-457.
50. Xiao YQ, Malcolm K, Worthen GS, Gardai S, Schiemann WP, Fadok VA, Bratton DL, Henson PM. 2002. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J Biol Chem 277: 14884-14893.
51. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM. 1996. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.
52. Yu L, Hebert MC, Zhang YE. 2002. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 21: 3749-3759.
53. Zhang YE. 2009. Non-Smad pathways in TGF-β signaling. Cell Res 19: 128-139.